InvestSMART

EBR Systems Inc (ASX:EBR)

ALERT: Price-sensitive ASX Announcement for EBR
Current share price for EBR : $0.295 0.02 (7.27%)+
Announcement
Release
31 Jul 2026 9:11AM
Price at Release
$0.275
Full Release
download
Summary
EBR Systems, Inc., based in Silicon Valley, is committed to enhancing the treatment of cardiac rhythm diseases using its innovative WiSE technology, which offers wireless cardiac pacing and eliminates the need for traditional pacing leads. Recently, two patients experienced serious complications after receiving WiSE system implants, resulting in one fatality. These cases were linked to a known risk that can be mitigated with proper procedures. An internal investigation by EBR concluded these were isolated incidents, and the company continues its commercial activities. The WiSE system has FDA approval and includes specific safety protocols to address potential risks. EBR is conducting an investor webinar to further discuss these developments and its preliminary Q2 2026 results.
Key Points
  • EBR Systems, Inc. is focused on improving cardiac rhythm disease treatment through wireless cardiac pacing.
  • The WiSE technology developed by EBR eliminates the need for cardiac pacing leads, reducing complications.
  • Two patients developed complications following WiSE system implantation, one resulting in death.
  • The incidents were isolated and linked to a known risk; EBR conducted an internal investigation.
  • The company's internal assessment found no ongoing concerns, and commercial implants continue.
  • WiSE system labeling includes precautions for ultrasound exposure to mitigate risks.
  • EBR plans to host an investor webinar to discuss the announcement and preliminary Q2 2026 results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.